Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin vs omeprazole for treatment of gastroesophageal reflux disease
TCTR20230330010Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin, omeprazole in gastroesophageal reflux disease (GERD), sponsored by Phramongkutklao Hospital. Started Sep 2021; status: completed.
02
Drugs
curcuminomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on TCTR20230330010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230330010.